We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+21.81%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$593M
AUM Growth
-$62.3M
Cap. Flow
-$26.5M
Cap. Flow %
-4.47%
Top 10 Hldgs %
74.27%
Holding
76
New
22
Increased
11
Reduced
12
Closed
25

Top Buys

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$30.5M
2
ISRG icon
Intuitive Surgical
ISRG
+$9.09M
3
GKOS icon
Glaukos
GKOS
+$7.06M
4
MGX icon
Metagenomi Therapeutics
MGX
+$5.3M
5
MSOS icon
AdvisorShares Pure US Cannabis ETF
MSOS
+$3.52M

Top Sells

Rank Stock Value
1
MDVL
MedAvail Holdings, Inc. Common Stock
MDVL
+$328M
2
QTRX icon
Quanterix
QTRX
+$6.82M
3
ESTA icon
Establishment Labs
ESTA
+$6.28M
4
RCEL icon
Avita Medical
RCEL
+$5.28M
5
PODD icon
Insulet
PODD
+$2.71M

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLGCW
76
DELISTED
SomaLogic, Inc. Warrant
SLGCW
– –
-173,876
Closed -$20.9K
1 2 3
4

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2024 Portfolio in Review

As of Q1 2024, Pura Vida Investments held 76 positions worth $593M, down 9.5% from $656M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Pura Vida Investments withdrew a net $26.5M in Q1 2024, closing 25 positions and reducing 12 holdings. Its most notable exit was MedAvail Holdings, Inc. Common Stock, an estimated $328M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 64% a quarter earlier, followed by Consumer Discretionary.

Against the trend, Pura Vida Investments opened a new position in Exact Sciences worth $33.3M.

  • Pura Vida Investments's largest Q1 2024 buy was Exact Sciences: 481,910 shares worth $33.3M.
  • Pura Vida Investments added most to AdvisorShares Pure US Cannabis ETF in Q1 2024, an estimated $3.52M increase.
  • Pura Vida Investments's biggest Q1 2024 reduction was Quanterix, cutting an estimated $6.82M.
  • Pura Vida Investments fully exited MedAvail Holdings, Inc. Common Stock in Q1 2024, selling an estimated $328M.
  • Pura Vida Investments's ten largest holdings make up 74% of its $593M portfolio in Q1 2024.
  • Pura Vida Investments opened 22 new positions and closed 25 in Q1 2024.
  • Pura Vida Investments's portfolio value fell 9.5% quarter-over-quarter to $593M.

Based on Pura Vida Investments's 13F filing for Q1 2024, filed 15 May 2024.